Early prediction of decompensation ( <scp>EPOD</scp> ) score: Non‐invasive determination of cirrhosis decompensation risk-Reference-Cited by-同舟云学术

Early prediction of decompensation ( EPOD ) score: Non‐invasive determination of cirrhosis decompensation risk

Published:2022-02-03 Issue:3 Volume:42 Page:640-650
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Schneider Annika R. P.¹²^ORCID,Schneider Carolin V.³⁴,Schneider Kai Markus⁵⁶⁷,Baier Vanessa¹^ORCID,Schaper Steffen²,Diedrich Christian²,Coboeken Katrin²,Mayer Hannah²,Gu Wenyi⁸,Trebicka Jonel⁸⁹^ORCID,Blank Lars M.¹,Burghaus Rolf¹⁰^ORCID,Lippert Joerg¹⁰,Rader Daniel J.³⁴,Thaiss Christoph A.⁵⁶⁷,Schlender Jan‐Frederik²,Trautwein Christian¹¹,Kuepfer Lars¹²^ORCID

Affiliation:

1. Institute of Applied Microbiology ‐ iAMB, Aachen Biology and Biotechnology – ABBt RWTH Aachen University Aachen Germany

2. Systems Pharmacology & Medicine, Bayer AG Leverkusen Germany

3. Division of Translational Medicine and Human Genetics, The Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Genetics, The Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

5. Department of Microbiology, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

6. Institute for Immunology, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

7. Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

8. Medical Department I Frankfurt University Hospital Leverkusen Germany

9. European Foundation for Study of Chronic Liver Failure Barcelona Spain

10. Clinical Pharmacometrics, Bayer AG Wuppertal Germany

11. Department of Medicine III University Hospital Aachen Aachen Germany

12. Institute for Systems Medicine University Hospital RWTH Aachen Aachen Germany

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15161

Reference27 articles.

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

2. A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA

3. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

5. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted quantitative lipidomic uncovers lipid biomarkers for predicting the presence of compensated cirrhosis and discriminating decompensated cirrhosis from compensated cirrhosis;Clinical Chemistry and Laboratory Medicine (CCLM);2023-11-06

2. Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives;Frontiers in Medicine;2023-09-14

3. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis;World Journal of Gastroenterology;2023-08-28

4. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease;European Radiology;2023-03-10

5. Early prediction of decompensation score: A closer look!;Gastroenterology, Hepatology and Endoscopy Practice;2023